Advanced search
Publication Cover
Expert Review of Medical Devices Volume 9, 2012 - Issue 4
Submit an article Journal homepage
2,691
Views
17
CrossRef citations to date
0
Altmetric
Perspective

Remote monitoring of cardiovascular implanted electronic devices: a paradigm shift for the 21st century

Edmond M Cronin Department of Cardiovascular Medicine, Section of Electrophysiology and Pacing, Cleveland Clinic, J2-2, 9500 Euclid Avenue, Cleveland, OH 44106, USA. [email protected]
&
Niraj Varma Department of Cardiovascular Medicine, Section of Electrophysiology and Pacing, Cleveland Clinic, J2-2, 9500 Euclid Avenue, Cleveland, OH 44106, USA. [email protected]
Pages 367-376 | Published online: 09 Jan 2014

References

  • Mirowski M, Reid PR, Mower MM et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N. Engl. J. Med. 303(6), 322–324 (1980).
  • Wallbrück K, Stellbrink C, Santini M, Gill J, Hartmann A, Wunderlich E. The value of permanent follow-up of implantable pacemakers – first results of an European trial. Biomed. Tech. 47(Suppl. 1 Pt 2), 950–953 (2002).
  • Wilkoff BL, Auricchio A, Brugada J et al.; Heart Rhythm Society; European Heart Rhythm Association; American College of Cardiology; American Heart Association; European Society of Cardiology; Heart Failure Association of ESC; Heart Failure Society of America. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 5(6), 907–925 (2008).
  • Varma N, Epstein AE, Irimpen A, Schweikert R, Love C; TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 122(4), 325–332 (2010).
  • Heidbüchel H, Lioen P, Foulon S et al. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace 10(3), 351–357 (2008).
  • Crossley GH, Chen J, Choucair W et al.; PREFER Study Investigators. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J. Am. Coll. Cardiol. 54(22), 2012–2019 (2009).
  • Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH; CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J. Am. Coll. Cardiol. 57(10), 1181–1189 (2011).
  • Varma N, Pavri B, Stambler B, Michalski J, TRUST investigators. Effect of transmission reliability on remote follow up in ICD patients: automatic home monitoring in the TRUST trial. Europace 13(3), abstract P1026 (2011).
  • Saxon LA, Hayes DL, Gilliam FR et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 122(23), 2359–2367 (2010).
  • Hayes DL, Boehmer JP, Day JD et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8(9), 1469–1475 (2011).
  • Gilliam FR, Hayes DL, Boehmer JP et al. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study. J. Cardiovasc. Electrophysiol. 22(9), 1023–1029 (2011).
  • Medtronic Inc. Clinician Manual Supplement Protecta™ XT / Protecta™. Projected service life information related to remote monitoring. Manual no.: M945739A001A, Medtronic Inc., MN, USA (2010).
  • Varma N, Michalski J, Epstein AE, Schweikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ. Arrhythm. Electrophysiol. 3(5), 428–436 (2010).
  • Varma N. Remote monitoring for advisories: automatic early detection of silent lead failure. Pacing Clin. Electrophysiol. 32(4), 525–527 (2009).
  • Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 6(5), 605–610 (2009).
  • Varma N, Stambler B, Chun S. Detection of atrial fibrillation by implanted devices with wireless data transmission capability. Pacing Clin. Electrophysiol. 28(Suppl. 1), S133–S136 (2005).
  • Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace 11(1), 54–61 (2009).
  • Ricci RP, Morichelli L, Gargaro A, Laudadio MT, Santini M. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through monte carlo simulations. J. Cardiovasc. Electrophysiol. 20(11), 1244–1251 (2009).
  • Ip J, Waldo AL, Lip GY et al.; IMPACT Investigators. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Am. Heart J. 158(3), 364–370.e1 (2009).
  • Hasan A, Paul V. Telemonitoring in chronic heart failure. Eur. Heart J. 32(12), 1457–1464 (2011).
  • Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet 378(9792), 731–739 (2011).
  • Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring – the Home CARE pilot study. Clin. Res. Cardiol. 95(Suppl. 3), III29–III35 (2006).
  • Adamson PB, Smith AL, Abraham WT et al.; InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 110(16), 2389–2394 (2004).
  • Conraads VM, Tavazzi L, Santini M et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur. Heart J. 32(18), 2266–2273 (2011).
  • van Veldhuisen DJ, Braunschweig F, Conraads V et al.; DOT-HF Investigators. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124(16), 1719–1726 (2011).
  • Ewald GA, Gilliam FR, Sweeney RJ. Automated HF Decompensation Detection: results from the DECOmpensation DEtection Study (DECODE) [abstract]. J. Cardiac Fail. 15, S122 (2009).
  • Calcagnini G, Censi F, Floris M et al. Evaluation of electromagnetic interference of GSM mobile phones with pacemakers featuring remote monitoring functions. Pacing Clin. Electrophysiol. 29(4), 380–385 (2006).
  • Halperin D, Heydt-Benjamin TS, Ransford B et al. Pacemakers and implantable cardiac defibrillators: software radio attacks and zero-power defenses. Presented at: 2008 IEEE Symposium on Security and Privacy. Oakland, CA, USA, 18–21 May 2008.
  • Boriani G, Auricchio A, Klersy C et al.; European Heart Rhythm Association; Eucomed. Healthcare personnel resource burden related to in-clinic follow-up of cardiovascular implantable electronic devices: a European Heart Rhythm Association and Eucomed joint survey. Europace 13(8), 1166–1173 (2011).
  • Cronin EM, Ching EA, Varma N, Martin DO, Wilkoff BL, Lindsay BD. Remote monitoring of cardiovascular devices – a time and activity analysis. Heart Rhythm (2012) (In Press).
  • Movsowitz C, Mittal S. Remote patient management using implantable devices. J. Interv. Card. Electrophysiol. 31(1), 81–90 (2011).
  • Matlock DD. Big Brother is watching you: what do patients think about ICD home monitoring? Circulation 122(4), 319–321 (2010).
  • Al-Khatib SM, Piccini JP, Knight D, Stewart M, Clapp-Channing N, Sanders GD. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J. Cardiovasc. Electrophysiol. 21(5), 545–550 (2010).
  • Varma N, Stambler BS. Letter by Varma and Stambler regarding article, Big Brother is watching you: what do patients think about ICD home monitoring? Circulation 123(7), e247 (2011).
  • Schoenfeld MH, Compton SJ, Mead RH et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin. Electrophysiol. 27(6 Pt 1), 757–763 (2004).
  • Marzegalli M, Lunati M, Landolina M et al. Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation – ease of use, acceptance, and organizational implications. Pacing Clin. Electrophysiol. 31(10), 1259–1264 (2008).
  • Raatikainen MJ, Uusimaa P, van Ginneken MM, Janssen JP, Linnaluoto M. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace 10(10), 1145–1151 (2008).
  • Ando K, Koyama J, Abe Y et al. Feasibility evaluation of a remote monitoring system for implantable cardiac devices in Japan. Int. Heart J. 52(1), 39–43 (2011).
  • Ricci RP, Morichelli L, Quarta L et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace 12(5), 674–679 (2010).
  • Joseph GK, Wilkoff BL, Dresing T, Burkhardt J, Khaykin Y. Remote interrogation and monitoring of implantable cardioverter defibrillators. J. Interv. Card. Electrophysiol. 11(2), 161–166 (2004).
  • Fauchier L, Sadoul N, Kouakam C et al. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin. Electrophysiol. 28(Suppl. 1), S255–S259 (2005).
  • Burri H, Heidbüchel H, Jung W, Brugada P. Remote monitoring: a cost or an investment? Europace 13(Suppl. 2), ii44–ii48 (2011).
  • Boriani G, Burri H, Mantovani LG et al. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace 13(Suppl. 2), ii59–ii65 (2011).
  • Powell BD, Cha YM, Asirvatham SJ et al. Implantable cardioverter defibrillator electrogram adjudication for device registries: methodology and observations from ALTITUDE. Pacing Clin. Electrophysiol. 34(8), 1003–1012 (2011).
  • Wilkoff BL, Kudenchuk PJ, Buxton AE et al.; DAVID II Investigators. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J. Am. Coll. Cardiol. 53(10), 872–880 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.